Abstract:Abstract Background The chronic inflammation of Ulcerative Colitis (UC) causes excessive extracellular matrix (ECM) remodeling, resulting in clinical complications. Currently, endoscopic evaluation remains the gold standard method for determining disease activity. However, due to its invasiveness and accompanying patient discomfort, novel methods are wanted. Focusing on type III collagen, a major component of the intestinal ECM, we sought to investigate three blood-based neoepitope biomarkers of type III collagen formation, degradation, and fibrosis resolution as surrogate markers of disease activity. Methods Fifty-one patients with UC were scored endoscopically at weeks 0 (W0) and 24 (W24), according to the total Mayo score (TMS) and the UC Endoscopic Index of Severity (UCEIS). Three biomarkers of type III collagen remodeling, PRO-C3 (formation), C3M (MMP-9 degradation), and CTX-III (fibrosis resolution), were measured in the sera of patients and evaluated against the disease activity scores. Patients were grouped based on their disease activity score, and the biomarkers were evaluated by one-way ANOVA, correcting for multiple comparisons using Tukey (parametric data) or Dunn’s test (nonparametric). Results Grouping patients according to the TMS at W0, patients with severe disease had elevated serum C3M compared to patients with mild or moderate disease (p<0.05 and <0.01) (Figure 1A). Based on the UCEIS, patients with a severe disease presented with reduced CTX-III than moderate disease activity (p<0.05) (Figure 1C). While not statistically significant, a numerical trend of elevated C3M levels with increasing endoscopic disease activity was observed at W24 (Figure 1B). No statistically significant results were achieved evaluating C3M according to the UCEIS score, CTX-III according to the TMS or PRO-C3 according to the TMS and UCEIS score (Data not shown). Conclusion The serum levels of C3M were elevated in patients with UC at W0 when scoring their endoscopic disease activity using the TMS. At W24, a similar trend of elevated C3M with increasing disease activity could be observed. Using the UCEIS score, the CTX-III biomarker reflecting type III collagen resolution was reduced in patients with severe endoscopic disease. The data suggest an elevation of MMP-9 catalyzed type III collagen degradation with disease severity and reduced type III collagen resolution. The PRO-C3 biomarker provided no statistical value in the current study.

Different Expression of Cysteine-aspartic Acid Protease-3 in Patients with Inflammatory Bowel Cisease

[Expression of Suppressor of Cytokine Signaling-3 and Caspase-3 in Endometriosis and Their Correlation].

Correlation Between Different Scoring Indexes of Capsule Endoscopy and Disease Activity in Crohn's Disease

Predictive Value of Serum Caspase-Cleaved Cytokeratin-18 Concentrations after Acute Intracerebral Hemorrhage

The Level of Serum Matrix Metalloproteinase-3 and Its Significance in Patients with Ankylosing Spondylitis

[Expression of Caspase Apoptosis Pathway Genes Mrna in Colorectal Cancer and Polyps].

The sensitivity and specificity of CT enterography comprehensive score in evaluating the activity of Crohn's disease

Matrix metalloproteinase-3 and-9 : possible biomarkers of infliximab efficacy in ankylosing spondylitis ( AS ) ?

IDDF2019-ABS-0186 Correlation Between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel Disease

Clinical value of plasma AT-Ⅲ and serum PCT, IL-6 levels and the evaluations of disease activity in Crohn's disease

Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.

The expression significance of caspase-3 in the tissne of liver cancer and the relationship with HBV infection

Study on Joint Detection of Serological Markers in the Diagnosis of Crohn's Disease

Changes of serum C-reactive protein in patients with Crohn's disease

Usefulness of Serum Tryptase Level As an Independent Biomarker for Coronary Plaque Instability in a Chinese Population.

Clinical Significance Of Anti-Sacchromyces Cerevisiae Antibody In Crohn'S Disease: A Single-Center Study

Expressions of DcR3 and caspase-3 and their significance in colorectal adenocarcinoma and precancerous lesions

Caspase-3 over-expression is associated with poor overall survival and clinicopathological parameters in breast cancer: a meta-analysis of 3091 cases.

P136 Blood-based biomarkers of type III collagen remodeling as surrogate markers of endoscopic disease activity in patients with Ulcerative Colitis

Decreased Serum CTRP3 level was associated with connective tissue diseases

Correlation between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel Disease